Annotation Detail for ADNP2
Basic Information
Top
| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ADNP2 mRNA | decreases expression | 20382639
20018196
19150397
|
| D016572 |
Cyclosporine |
Cyclosporine results in increased expression of ADNP2 mRNA | increases expression | 20106945
|
| D008094 |
Lithium |
Lithium results in increased expression of ADNP2 mRNA | increases expression | 19949822
|
| C004648 |
testosterone enanthate |
testosterone enanthate affects the expression of ADNP2 mRNA | affects expression | 17440010
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000544 |
Alzheimer Disease |
|
Lithium |
3.53 | 19621015 |
| MESH:D001714 |
Bipolar Disorder |
|
Lithium |
4.49 | 19153942 20338123 17594078 20046352 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7.44 | 20889678 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
7.44 | 12371664 |
| MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.21 | 19486331 |
| MESH:D007644 |
Darier Disease |
|
Lithium |
6.54 | 20338123 |
| MESH:D018500 |
Diabetes Insipidus, Nephrogenic |
|
Lithium |
6.31 | 19244398 |
| MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.15 | 20426865 |
| MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
3.28 | 19224547 |
| MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.70 | 12639820 12168785 |
| MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.85 | 8708960 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Lithium |
4.39 | 19638421 |
| MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
5.05 | 15720958 |
| MESH:D019247 |
HIV Wasting Syndrome |
|
testosterone enanthate |
6.47 | 17440010 |
| MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.21 | 10903974 |
| MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
5.16 | 15604871 |
| MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.54 | 8314463 10903974 18776723 |
| MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
3.08 | 12371664 |
| MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.51 | 16801185 |
| MESH:D009203 |
Myocardial Infarction |
|
Lithium |
4.06 | 16288908 |
| MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
5.16 | 17954296 |
| MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.65 | 18481113 19348381 |
| MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.59 | 12371664 |
| MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.33 | 16882103 |
| MESH:D012640 |
Seizures |
|
Lithium |
4.24 | 19660546 |
| MESH:D013226 |
Status Epilepticus |
|
Lithium |
6.51 | 19430551 19570321 19951488 |
| MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.71 | 1336536 |
| MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
5.16 | 17120751 |
Related Pathway Information